Safety of Negative FrActional Flow Reserve in Patients With ChallEnging Lesions

NCT02590926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 285

Last updated 2017-06-02

No results posted yet for this study

Summary

Fractional Flow Reserve (FFR) has recently emerged and has been largely validated as a safe and efficacious way of ischemia testing for patients with stable angina. The new recently ESC guidelines have strongly suggested a FFR based approach for patients with stable angina, also for those with challenging lesions like left main disease, severe multivessel stenosis for heart failure patients and those with single remaining vessels although left main disease and an ejection fraction less than 30% are exclusion criteria of the randomized controlled trials on this topic. Consequently the investigators performed a prospective multicenter study to understand the safety and efficacy of a FFR based approach for these patients.

Conditions

  • Fractional Flow Reserve, Myocardial

Interventions

PROCEDURE

Fractional Flow Reserve, Myocardial

The ratio of maximum blood flow to the myocardium with coronary stenosis present, to the maximum equivalent blood flow without stenosis.

Sponsors & Collaborators

  • A.O.U. Città della Salute e della Scienza

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-26
Primary Completion
2016-09-05
Completion
2017-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02590926 on ClinicalTrials.gov